SCHEMBL31421403

SCHEMBL31421403

CC(C)(C)OC(=O)NCCOCc1cnn[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.41
▸ CA12 O43570 6/20 0.40
▸ CA1 P00915 6/20 0.40
▸ CA2 P00918 6/20 0.40
▸ CA9 Q16790 6/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ GFER P55789 1/20 0.40
▸ IDO1 P14902 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.38
▸ BCHE P06276 1/20 0.38
▸ STK17B O94768 1/20 0.38
▸ STK17A Q9UEE5 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ SCN9A Q15858 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ ADORA2A P29274 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30473404 0.81 KDM4E (0.47) NPSR1ALDH1A1GFERTDP1BCHE
SCHEMBL10259122 0.75 NPSR1 (0.43) NPSR1ALDH1A1GFERIDO1TDP1
SCHEMBL13055393 0.73 TDP1 (0.58) NPSR1CA12CA1CA2CA9
SCHEMBL10197629 0.73 TDP1 (0.46) NPSR1CA12CA1CA2CA9
SCHEMBL9573408 0.72 HRH3 (0.48) —
SCHEMBL10073751 0.72 TDP1 (0.53) NPSR1CA12CA1CA2CA9
SCHEMBL22276648 0.72 TDP1 (0.56) NPSR1CA12CA1CA2CA9
SCHEMBL22276641 0.72 TDP1 (0.56) NPSR1CA12CA1CA2CA9
SCHEMBL12885084 0.72 TDP1 (0.56) NPSR1CA12CA1CA2CA9
SCHEMBL506649 0.71 IDO1 (0.62) CA12CA1CA2CA9IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-04-24 — — US disclosed
WO-2025064718-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, NRAS NPSR1 4718/4885CA12 4633/4885CA1 4801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback